Search company, investor...

GCH

gchchem.com

Founded Year

2002

Stage

IPO | IPO

Date of IPO

6/6/2021

About GCH

GCH (688625.SH) develops, manufactures and markets technologically advanced and high value added products, including nucleator, synthetic hydrotalcite, non-dust one-pack, master batch, flame retardant synergist, anti-oxidant, and light stabilizers. It is based in Guangzhou, Guangdong.

Headquarters Location

B-4108 China Shine Plaza No.9, Linhexi Road, Tianhe District

Guangzhou, Guangdong,

China

Missing: GCH's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: GCH's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing GCH

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned GCH in 1 CB Insights research brief, most recently on Mar 2, 2020.

GCH Frequently Asked Questions (FAQ)

  • When was GCH founded?

    GCH was founded in 2002.

  • Where is GCH's headquarters?

    GCH's headquarters is located at B-4108 China Shine Plaza, Guangzhou.

  • What is GCH's latest funding round?

    GCH's latest funding round is IPO.

  • Who are the investors of GCH?

    Investors of GCH include Qihong Investment.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.